Founded in 1996, LifeSensors is a privately held biotechnology company located 35 miles west of Philadelphia. The main focus at LifeSensors is to develop enabling technologies to translate genome into proteome. The technology platform is based on an important family of proteins called ubiquitin or ubiquitin-like proteins (UBL), such as SUMO (Small Ubiquitin-like MOdifer). LifeSensors has filed patents to cover the use of UBL and SUMO as gene fusions to enhance expression and facilitate rapid purification of recombinant proteins. Currently, LifeSensors is expanding its protein expression and purification capabilities to develop human receptor based protein chips for drug discovery and diagnostics.
Dr. Yitong Dong
Dr. Yitong Dong has recently been awarded funding to study custom composite nanocrystals, which could help to create advanced quantum communication technologies. Learn more about this project in this interview.
Roey Elnathan, Ph.D.
We take a closer look at the fusion of nanotechnology and CAR-T therapy through our interview with Dr. Roey Elnathan about a new approach that harnesses the capabilities of nanoneedles to efficiently deliver genetic materials to target cells.
In this interview, Laura-Isabelle, the Director of Sales at Photon etc., talks to AzoNano about how spectral imaging can help improve the next generation of solar cells.
The Verifire™ interferometer system provides fast and reliable measurements of surface form error.
Discover the compact, fast rotary table V-610 for precision testing and manufacture.
The Diamond Interaction Chamber (DIXC) is integral to the NanoGenizer high-pressure homogenizer.